Skip to main content
GBCS logo

GBCS · Selectis Health, Inc. · Shareholders & Ownership

Track GBCS — free
$5.73 -0.02 (-0.35%) At close · Oct 1
Market Cap
$17.57M
Shares
3.07M
Volume · Oct 1 1400 Avg daily vol (3M) 2509

Every disclosed holder of GBCS in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.

Who Owns GBCS

Holder group Shares % Out
Institutional (13F) 0 0.00%
Insiders (Forms 3, 4, 5) 227,319 7.41%
13D/G-only blocks 0 0.00%
Remaining 2,839,740 92.59%
Registered funds (N-PORT, not summed) 0 0.00%

Shares outstanding: 3,067,059, the issuer's latest cover-page count restated onto today's split basis.

13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.

Holders of GBCS

# Holder Shares
1
Baller Lance
Insider CIK 1296186 · Dec 18, 2025
Director, 10% Owner, issuer-wide
168,632
2
Desmond Adam
Insider CIK 1696337 · Dec 31, 2025
Director, CEO, issuer-wide
38,434
3
Lund Kent Jeffrey
Insider CIK 1369753 · Jan 1, 2026
Director, issuer-wide
19,253
4
Eckhart Krystal Diane
Insider CIK 2136457 · May 15, 2026
INTERIM CEO/INTERIM CFO, issuer-wide
1,000

Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.

Key facts CIK 727346 CUSIP 816291108 Visit website Investor relations